Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 20

1.

WINCS Harmoni: Closed-loop dynamic neurochemical control of therapeutic interventions.

Lee KH, Lujan JL, Trevathan JK, Ross EK, Bartoletta JJ, Park HO, Paek SB, Nicolai EN, Lee JH, Min HK, Kimble CJ, Blaha CD, Bennet KE.

Sci Rep. 2017 Apr 28;7:46675. doi: 10.1038/srep46675.

2.

Inflammation Effects on Motivation and Motor Activity: Role of Dopamine.

Felger JC, Treadway MT.

Neuropsychopharmacology. 2017 Jan;42(1):216-241. doi: 10.1038/npp.2016.143. Epub 2016 Aug 2.

PMID:
27480574
3.

Striatal dopamine type 2 receptor availability in anorexia nervosa.

Broft A, Slifstein M, Osborne J, Kothari P, Morim S, Shingleton R, Kenney L, Vallabhajosula S, Attia E, Martinez D, Timothy Walsh B.

Psychiatry Res. 2015 Sep 30;233(3):380-7. doi: 10.1016/j.pscychresns.2015.06.013. Epub 2015 Jul 26.

4.

Striatal dopamine D2/3 receptor availability in treatment resistant depression.

de Kwaasteniet BP, Pinto C, Ruhé HG, van Wingen GA, Booij J, Denys D.

PLoS One. 2014 Nov 20;9(11):e113612. doi: 10.1371/journal.pone.0113612. eCollection 2014. Erratum in: PLoS One. 2015;10(8):e0135764. Ruhé, Eric H G [corrected to Ruhé, Henricus G].

5.

Imaging the pathophysiology of major depressive disorder - from localist models to circuit-based analysis.

Treadway MT, Pizzagalli DA.

Biol Mood Anxiety Disord. 2014 Mar 7;4(1):5. doi: 10.1186/2045-5380-4-5.

6.

Molecular imaging as a guide for the treatment of central nervous system disorders.

Kim E, Howes OD, Kapur S.

Dialogues Clin Neurosci. 2013 Sep;15(3):315-28. Review.

7.

Reward circuitry dysfunction in psychiatric and neurodevelopmental disorders and genetic syndromes: animal models and clinical findings.

Dichter GS, Damiano CA, Allen JA.

J Neurodev Disord. 2012 Jul 6;4(1):19. doi: 10.1186/1866-1955-4-19.

8.

Neurobiology of chronic mild stress: parallels to major depression.

Hill MN, Hellemans KG, Verma P, Gorzalka BB, Weinberg J.

Neurosci Biobehav Rev. 2012 Oct;36(9):2085-117. doi: 10.1016/j.neubiorev.2012.07.001. Epub 2012 Jul 7. Review.

9.

Striatal dopamine in bulimia nervosa: a PET imaging study.

Broft A, Shingleton R, Kaufman J, Liu F, Kumar D, Slifstein M, Abi-Dargham A, Schebendach J, Van Heertum R, Attia E, Martinez D, Walsh BT.

Int J Eat Disord. 2012 Jul;45(5):648-56. doi: 10.1002/eat.20984. Epub 2012 Feb 13.

10.

Postpartum and depression status are associated with lower [[¹¹C]raclopride BP(ND) in reproductive-age women.

Moses-Kolko EL, Price JC, Wisner KL, Hanusa BH, Meltzer CC, Berga SL, Grace AA, di Scalea TL, Kaye WH, Becker C, Drevets WC.

Neuropsychopharmacology. 2012 May;37(6):1422-32. doi: 10.1038/npp.2011.328. Epub 2012 Jan 18.

11.

Functional neuroimaging in geriatric depression.

Gunning FM, Smith GS.

Psychiatr Clin North Am. 2011 Jun;34(2):403-22, viii. doi: 10.1016/j.psc.2011.02.010. Epub 2011 Apr 8. Review.

12.

Correlation of individual differences in schizotypal personality traits with amphetamine-induced dopamine release in striatal and extrastriatal brain regions.

Woodward ND, Cowan RL, Park S, Ansari MS, Baldwin RM, Li R, Doop M, Kessler RM, Zald DH.

Am J Psychiatry. 2011 Apr;168(4):418-26. doi: 10.1176/appi.ajp.2010.10020165. Epub 2010 Dec 15.

13.

Reconsidering anhedonia in depression: lessons from translational neuroscience.

Treadway MT, Zald DH.

Neurosci Biobehav Rev. 2011 Jan;35(3):537-55. doi: 10.1016/j.neubiorev.2010.06.006. Epub 2010 Jul 11. Review.

14.

Effect of a history of major depressive disorder on smoking-induced dopamine release.

Brody AL, Olmstead RE, Abrams AL, Costello MR, Khan A, Kozman D, Saxena S, Farahi J, London ED, Mandelkern MA.

Biol Psychiatry. 2009 Nov 1;66(9):898-901. doi: 10.1016/j.biopsych.2009.06.011. Epub 2009 Jul 29.

15.

Dopaminergic activity in depressed smokers: a positron emission tomography study.

Busto UE, Redden L, Mayberg H, Kapur S, Houle S, Zawertailo LA.

Synapse. 2009 Aug;63(8):681-9. doi: 10.1002/syn.20646.

16.

The dopamine hypothesis of schizophrenia: version III--the final common pathway.

Howes OD, Kapur S.

Schizophr Bull. 2009 May;35(3):549-62. doi: 10.1093/schbul/sbp006. Epub 2009 Mar 26. Review.

17.

Dopamine type-1 receptor binding in major depressive disorder assessed using positron emission tomography and [11C]NNC-112.

Cannon DM, Klaver JM, Peck SA, Rallis-Voak D, Erickson K, Drevets WC.

Neuropsychopharmacology. 2009 Apr;34(5):1277-87. doi: 10.1038/npp.2008.194. Epub 2008 Oct 22.

18.

Dopamine receptor gene expression in human amygdaloid nuclei: elevated D4 receptor mRNA in major depression.

Xiang L, Szebeni K, Szebeni A, Klimek V, Stockmeier CA, Karolewicz B, Kalbfleisch J, Ordway GA.

Brain Res. 2008 May 1;1207:214-24. doi: 10.1016/j.brainres.2008.02.009. Epub 2008 Feb 14.

19.

Molecular imaging studies of the striatal dopaminergic system in psychosis and predictions for the prodromal phase of psychosis.

Howes OD, Montgomery AJ, Asselin MC, Murray RM, Grasby PM, McGuire PK.

Br J Psychiatry Suppl. 2007 Dec;51:s13-8. doi: 10.1192/bjp.191.51.s13. Review.

20.

The subjective and cognitive effects of acute phenylalanine and tyrosine depletion in patients recovered from depression.

Roiser JP, McLean A, Ogilvie AD, Blackwell AD, Bamber DJ, Goodyer I, Jones PB, Sahakian BJ.

Neuropsychopharmacology. 2005 Apr;30(4):775-85.

Supplemental Content

Support Center